Scientists Investigate Omicron Subvariant BA.2

This strain of SARS-CoV-2 is causing new outbreaks in Europe and Asia and may spread slightly faster than the better-known BA.1 Omicron subvariant, although it’s too early to say for sure.

Written byCatherine Offord
| 2 min read
Illustration of SARS-CoV-2 virus in red and blue
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researchers are monitoring the behavior of BA.2, a subvariant of SARS-CoV-2 that is responsible for a number of outbreaks ongoing in Europe and some parts of Asia. First described in November, the strain is a subtype of the Omicron variant, and preliminary data hint that it might spread slightly faster than the better-studied BA.1, the subtype responsible for most Omicron outbreaks to date.

“Among all the lineages of Omicron, this is the one showing a higher increase of cases,” Ramon Lorenzo-Redondo, assistant professor of medicine for infectious diseases at Northwestern University Feinberg School of Medicine in Chicago, tells CNN. “But we have to be careful in interpreting that, because higher increases from a very low number are easier to observe.”

The BA.1 version of Omicron has been the dominant strain in many countries for weeks, and nearly all Omicron infections in the US at the moment are due to this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies